Cardiovascular Effects of CAR T Cell Therapy

Background: Anti-CD19 chimeric antigen receptor (CAR) T cell therapy holds great promise in the treatment of patients with hematologic malignancies. A high occurrence of cardiac dysfunction has been noted in children treated with CAR T cell therapy. Objectives: The aim of this study was to define th...

Full description

Bibliographic Details
Main Authors: Bénédicte Lefebvre, MD, Yu Kang, MD, PhD, Amanda M. Smith, MA, Noelle V. Frey, MD, Joseph R. Carver, MD, Marielle Scherrer-Crosbie, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:JACC. CardioOncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087320300831